Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pipamperone Add-on in Schizophrenia
NCT01450514Phase 2Completed
- Sponsor
- PharmaNeuroBoost
- Start
- Mar 2012
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pipamperone in schizophrenia, schizoaffective disorder, sponsored by PharmaNeuroBoost. Started Mar 2012; status: completed.
02
Drugs
pipamperone
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT01450514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01450514.